Dokuz Eylul University, School of Medicine, Department of Urology, Izmir, Turkey.
Expert Rev Anticancer Ther. 2009 Dec;9(12):1753-5. doi: 10.1586/era.09.154.
Renal cell carcinoma is a hot topic in urologic oncology, thanks to a better understanding of the disease mechanisms, which has resulted in the developments and approval of targeted therapies. Six agents are now approved in the treatment of metastatic renal cell carcinoma. Some new information was presented at the recent Joint 15th European Cancer Organisation (ECCO) - 34th European Society of Medical Oncology (ESMO) Multidisciplinary Congress in Berlin. This article highlights the most important presentations at this meeting.
肾细胞癌是泌尿肿瘤学的热门话题，这要归功于对疾病机制的更好理解，这导致了靶向治疗的发展和批准。目前有六种药物被批准用于治疗转移性肾细胞癌。在最近于柏林举行的第 15 届欧洲癌症组织（ECCO）-第 34 届欧洲肿瘤内科学会（ESMO）多学科大会上，有一些新信息公布。本文重点介绍了本次会议的最重要的报告。
